Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice TargetHot
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.